For Healthcare Professionals Only
Clinical Insights and Patient Perspectives for HCP Education
- Osteoporosis
- Rheumatology
- Gastroenterology
This collection of educational materials was independently developed by S. Karger Publishers Ltd. and made possible through an educational grant from Fresenius Kabi Swiss BioSim GmbH.
Osteoporosis Animation and Course Videos
The pathophysiology of osteoperosis
This animation explains the pathophysiology of osteoperosis. It is part of the course Fast Facts: Medical Management of Osteoperosis, which is free-to-access at this link. It is part of the course Fast Facts: Medical Management of Osteoporosis, which is free-to-access at this link.
Osteoporosis: intervention & risk thresholds
Professor Adami explains the Prof. Adami explains the concepts of number needed to treat (NNT) and number needed to harm (NNH), and why these are relevant to the management of osteoporosis. The video is part of the course Fast Facts: Medical Management of Osteoporosis, which is free-to-access at this link.
Osteoporosis: therapeutic decision-making
Prof. Elaine Dennison explains the key considerations for making therapeutic decisions in osteoporosis. The video is part of the course Fast Facts: Medical Management of Osteoporosis, which is free-to-access at this link.
Osteoporosis Expert Perspectives: Clinical Practice, Research, and Patient Impact
Episode 1: Osteoporosis in the Clinic
Prof. Elaine Dennison from the University of Southampton speaks with us in this special series to discuss the clinical presentation of osteoporosis, the treatment landscape, and the risks associated with treatment types, including no treatment at all.
Episode 2: Osteoporosis in the Research Lab
In this episode of our special series examining osteoporosis care, we speak with Prof. Serge Ferrari from the University of Geneva about what is changing for patients and clinicians.
Episode 3: Osteoporosis in Patients’ Lives
We spoke with Prof. Peyman Hadji about his clinical experience in assessing symptoms and deciding on treatment plans for those affected.
Osteoporosis Patient Resources: Practical Guidance for Living with Osteoporosis
Osteoporosis in Daily Life
Join Brenda, a patient living with osteoporosis, as she speaks with Donna Rowe, Clinical Nurse Specialist at Imperial College Healthcare NHS Trust in London. In this helpful conversation, they discuss what happens when you’re referred to the Fracture Liaison Service, the different treatment options available for osteoporosis, and practical tips for managing the condition day-to-day.
Osteoporosis: Don’t Wait for a Break (Patient Animation)
Your bone health matters at every age. This short animation shows how early action can prevent osteoporosis later in life.
Rheumatology IL-6R Course Animation and Videos
Fast Facts: IL-6 Receptor Inhibition
Interleukin-6 receptor inhibition: mechanism of action
This animation explains the mechanism of action of interleukin-6, and its role in treatment of different types of arthritis.
The video is part of the Fast Facts: Interleukin-6 Receptor courses:
Fast Facts: Interleukin-6 Receptor Inhibition in Giant Cell Arteritis
Fast Facts: Interleukin-6 Receptor Inhibition in Juvenile Idiopathic Arthritis
Fast Facts: Interleukin-6 Receptor Inhibition in Rheumatoid Arthritis
Fast Facts: IL-6 Receptor Inhibition in Giant Cell Arteritis
Clinical presentation of giant cell arthritis
Prof. David Saadoun explains important considerations around the clinical presentation of giant cell arthritis. The video is part of the course Fast Facts: Interleukin-6 Receptor Inhibition in Giant Cell Arteritis, which is free-to-access at this link.
Treatment of giant cell arthritis
Dr. Christian Dejaco explains when tocilizumab can be initiated in patients ‘at risk of glucocorticoid-related adverse events. The video is part of the course Fast Facts: Interleukin-6 Receptor Inhibition in Giant Cell Arteritis, which is free-to-access at this link.
IL6 receptor inhibition in giant cell arthritis
Dr. Georgina Espígol-Frigolé and Dr. Christian Dejaco explain how tocilizumab and its biosimilars are currently used in the management of giant cell arthritis. The video is part of the course Fast Facts: Interleukin-6 Receptor Inhibition in Giant Cell Arteritis, which is free-to-access at this link.
Monitoring for giant cell arthritis
Prof. Bhaskar Dasgupta explains what optimal monitoring for patients with giant cell arteritis should look like. The video is part of the course Fast Facts: Interleukin-6 Receptor Inhibition in Giant Cell Arteritis, which is free-to-access at this link.
Fast Facts: Interleukin-6 Receptor Inhibition in Juvenile Idiopathic Arthritis
Introduction to juvenile idiopathic arthritis
Prof. Fabrizio de Benedetti explains the differences between systemic juvenile idiopathic arthritis and polyarticular juvenile idiopathic arthritis, and how these conditions affect patients and their families. The video is part of the course Fast Facts: Interleukin-6 Receptor Inhibition in Juvenile Idiopathic Arthritis, which is free-to-access at this link.
Role of IL-6 in juvenile idiopathic arthritis
Dr. Marco Gattorno explains the the role of interleukin 6 receptor inhibition in juvenile idiopathic arthritis. It is part of the course Fast Facts: Interleukin-6 Receptor Inhibition in Juvenile Idiopathic Arthritis, which is free-to-access at this link.
Role of IL-6R inhibition in JIA-associated uveitis
Prof. Athimalaipet Ramanan elaborates on how interleukin-6 receptor inhibition therapy is prescribed and monitored in patients with JIA-associated uveitis. The video is part of the course Fast Facts: IL-6Ri in Juvenile Idiopathic Arthritis, which is free-to-access at this link.
Fast Facts: Interleukin-6 Receptor Inhibition in Rheumatoid Arthritis
Treatments in rheumatoid arthritis
Jérôme Avouac discusses the management of rheumatoid arthritis in the context of the current treatment landscape. This video is part of the course Fast Facts: IL-6 Receptor Inhibition in Rheumatoid Arthritis, which is free-to-access at this link.
Interleukin-6 in rheumatoid arthritis
Christopher Holroyd explains the use of IL-6R inhibitors in rheumatoid arthritis. This video is part of the course Fast Facts: IL-6 Receptor Inhibition in Rheumatoid Arthritis, which is free-to-access at this link.
Initiating IL-6 Receptor Inhibitor Therapy
In this interview, Prof. Taylor explains factors to consider when initiating IL-6R inhibitor therapy in patients with rheumatoid arthritis. It is part of the course Fast Facts: Interleukin-6 Receptor Inhibition in Rheumatoid Arthritis, which is free-to-access at this link.